Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study Patients (age ≥ 12 years) with newly diagnosed moderate or severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback